iRadimed Corporation (IRMD) vs Tandem Diabetes Care, Inc. (TNDM)

iRadimed Corporation and Tandem Diabetes Care, Inc. are both Medical Devices companies. iRadimed Corporation and Tandem Diabetes Care, Inc. are of similar size ($1.1B and $1.1B). Tandem Diabetes Care, Inc. has negative trailing earnings, so its P/E is not meaningful; iRadimed Corporation trades at 47.1×. iRadimed Corporation grew revenue faster over the last twelve months: 11.2% against 3.96%. iRadimed Corporation has the higher net margin (26.7% vs −6.08%) and the higher return on invested capital (40.4% vs −10.3%). Across the 19 metrics below, iRadimed Corporation leads on 16 and Tandem Diabetes Care, Inc. on 3.

Valuation

Metric IRMD TNDM Medical Devices median
P/E 47.12 n/m 22.18
P/S 12.70 1.04 2.70
P/B 10.78 8.32 2.46
Price to free cash flow 46.51 n/m 22.53
EV/EBITDA 35.54 n/m 11.78
EV/Sales 12.01 1.18 2.38
Earnings yield 2.12% (5.92%) (8.22%)
Free cash flow yield 2.15% (8.83%) (7.80%)

Profitability

Metric IRMD TNDM Medical Devices median
Gross margin 75.86% 56.01% 56.01%
Operating margin 31.92% (4.40%) (15.03%)
Net margin 26.70% (6.08%) (20.40%)
Free cash flow margin 28.43% (2.56%) (7.24%)
Return on equity 23.52% (48.03%) (15.32%)
Return on assets 20.82% (6.24%) (19.72%)
Return on invested capital 40.36% (10.33%) (10.33%)

Growth

Metric IRMD TNDM Medical Devices median
Revenue growth (TTM) 11.21% 3.96% 8.80%
EPS growth (last fiscal year) 16.67% (106.80%) —
Revenue growth, 5-year CAGR 21.45% 15.26% 15.23%
Net income growth, 5-year CAGR 75.02% 0.00% 0.00%

Health

Metric IRMD TNDM Medical Devices median
Debt to equity 0.00 4.62 0.07
Current ratio 9.46 3.18 2.50
Net debt to EBITDA (1.87) (0.10) 0.49

Dividend

Metric IRMD TNDM Medical Devices median
Dividend yield 0.32% — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric IRMD TNDM Medical Devices median
Market cap 1.09b 1.06b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack